Cite
HARVARD Citation
Jin, S. et al. (n.d.). Lobeglitazone and pioglitazone as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, parallel‐group, active‐controlled, phase III clinical trial with a 28‐week extension. Diabetes, obesity & metabolism. 17 (6), pp. 599-602. [Online].